Retinoic Acid Mediates Visceral-Specific Adipogenic Defects of Human Adipose-Derived Stem Cells

Diabetes. 2016 May;65(5):1164-78. doi: 10.2337/db15-1315. Epub 2016 Mar 2.

Abstract

Increased visceral fat, rather than subcutaneous fat, during the onset of obesity is associated with a higher risk of developing metabolic diseases. The inherent adipogenic properties of human adipose-derived stem cells (ASCs) from visceral depots are compromised compared with those of ASCs from subcutaneous depots, but little is known about the underlying mechanisms. Using ontological analysis of global gene expression studies, we demonstrate that many genes involved in retinoic acid (RA) synthesis or regulated by RA are differentially expressed in human tissues and ASCs from subcutaneous and visceral fat. The endogenous level of RA is higher in visceral ASCs; this is associated with upregulation of the RA synthesis gene through the visceral-specific developmental factor WT1. Excessive RA-mediated activity impedes the adipogenic capability of ASCs at early but not late stages of adipogenesis, which can be reversed by antagonism of RA receptors or knockdown of WT1. Our results reveal the developmental origin of adipocytic properties and the pathophysiological contributions of visceral fat depots.

Publication types

  • Comparative Study
  • Validation Study

MeSH terms

  • Active Transport, Cell Nucleus / drug effects
  • Adipogenesis* / drug effects
  • Adult Stem Cells / cytology
  • Adult Stem Cells / drug effects
  • Adult Stem Cells / metabolism
  • Adult Stem Cells / pathology
  • Bariatric Surgery
  • Benzoates / pharmacology
  • Cells, Cultured
  • Down-Regulation* / drug effects
  • Gene Expression Profiling
  • Gene Expression Regulation, Developmental* / drug effects
  • Gene Ontology
  • Humans
  • Intra-Abdominal Fat / cytology
  • Intra-Abdominal Fat / drug effects
  • Intra-Abdominal Fat / metabolism*
  • Intra-Abdominal Fat / pathology
  • Middle Aged
  • Naphthalenes / pharmacology
  • Obesity, Morbid / metabolism
  • Obesity, Morbid / pathology
  • Obesity, Morbid / surgery
  • RNA Interference
  • Receptors, Retinoic Acid / agonists*
  • Receptors, Retinoic Acid / antagonists & inhibitors
  • Receptors, Retinoic Acid / metabolism
  • Response Elements / drug effects
  • Signal Transduction* / drug effects
  • Stilbenes / pharmacology
  • Subcutaneous Fat, Abdominal / cytology
  • Subcutaneous Fat, Abdominal / drug effects
  • Subcutaneous Fat, Abdominal / metabolism
  • Subcutaneous Fat, Abdominal / pathology
  • Tretinoin / metabolism*
  • Up-Regulation / drug effects
  • WT1 Proteins / antagonists & inhibitors
  • WT1 Proteins / genetics
  • WT1 Proteins / metabolism

Substances

  • 4-(2-(5,6-dihydro-5,5-dimethyl-8-(2-phenylethynyl)naphthalen-2-yl)ethen-1-yl)benzoic acid
  • Benzoates
  • Naphthalenes
  • Receptors, Retinoic Acid
  • Stilbenes
  • WT1 Proteins
  • WT1 protein, human
  • Tretinoin